U.S. Interventional Oncology Market (2025 - 2030) Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End Use, And Segment Forecasts

Market Segmentation

U.S. Interventional Oncology Technique Outlook (Revenue, USD Million, 2018 - 2030)
- Ablation Therapies
  - Radiofrequency Ablation (RFA)
  - Microwave Ablation (MWA)
  - Cryoablation
  - Laser Ablation
  - Irreversible Electroporation (IRE)
- Embolization Therapies
  - Transarterial Chemoembolization (TACE)
  - Transarterial Radioembolization (TARE)
- Biopsy Techniques
  - Core Needle Biopsy
  - Fine Needle Aspiration (FNA)
- Targeted Therapy Delivery Systems
  - Drug-Eluting Beads
  - Radioembolization
  - Drug-Eluting Stents
  - Injectable Hydrogels and Nanoparticles
  - Other Targeted Therapy Systems
- Image-Guided Procedures
  - Ultrasound Guidance
  - CT Scan Guidance
  - MRI Guidance
  - Fluoroscopy Guidance
U.S. Interventional Oncology Procedure Outlook (Revenue, USD Million, 2018 - 2030)
- Tumor Ablation
- Tumor Biopsy
- Vascular Interventions
- Palliative Care
U.S. Interventional Oncology Application Outlook (Revenue, USD Million, 2018 - 2030)
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer
- Breast Cancer
- Other Cancer
U.S. Interventional Oncology End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Specialty Clinics
- Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments